Celldex Therapeutics buy Morgan Stanley
Start price
09.05.25
/
50%
€16.30
Target price
09.05.26
€38.34
Performance (%)
74.29%
End price
10.05.26
€28.41
Summary
This prediction ended on 10.05.26 with a price of €28.41. With a performance of 74.29% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | -6.209% | -6.209% | 74.020% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% |
Comments by Morgan_Stanley for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its price target lowered by analysts at Morgan Stanley from $46.00 to $43.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€30.47
22.07.26
22.07.26
€35.07
22.07.27
22.07.27
17.16%
08:06
08:06
Stopped prediction by Morgan_Stanley for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€36.10
07.08.26
07.08.26
€39.92
07.08.27
07.08.27
-1.11%
08:06
08:06
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.03.25
20.03.25
€42.18
20.03.26
20.03.26
42.39%
21.03.26
21.03.26